CPT 4086F Aspirin/Clopidogrel Reimbursement | OpenPayer

Summary & Overview

CPT 4086F: Aspirin or Clopidogrel Prescription for CAD and Stroke Prevention

CPT code 4086F documents that a provider prescribes or the patient is actively taking aspirin or clopidogrel for prevention of coronary artery disease, stroke, or ischemic chest pain. Nationally, this measure captures an element of secondary prevention for patients at cardiovascular risk and informs quality measurement, medication adherence monitoring, and clinical performance reporting. The code is relevant across outpatient primary care and cardiology settings where antiplatelet therapy is initiated or maintained.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise clinical context for antiplatelet prescribing, an explanation of typical service settings, and guidance on what types of benchmarks and policy updates are commonly associated with this measure. The publication highlights how documentation using CPT code 4086F supports quality programs, impacts claims processing, and aligns with population health efforts focused on preventing recurrent cardiovascular events.

The report addresses: clinical rationale for aspirin and clopidogrel use; common billing and documentation considerations; expected sites of service; and where to look for related policy or performance measure updates. Data not provided in the input—such as specific modifiers, taxonomies, ICD-10 codes, and payer-specific rules—is noted as unavailable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareCPT 4086Fantiplatelet therapyaspirinclopidogrelcardiovascular preventionoutpatient caremedication managementquality measurementsecondary prevention

Billing Code Overview

CPT code 4086F indicates that the provider prescribes, or the patient is currently taking, aspirin or clopidogrel for prevention of cardiovascular events. The description notes use for prevention of coronary artery disease (CAD), stroke, and chest pain related to ischemic heart disease.

Service Type: Medication management / Secondary prevention therapy

Typical Site of Service: Outpatient clinic, primary care, cardiology clinic, or other ambulatory care settings

Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, payers, and service line.

Clinical & Coding Specifications

Clinical Context

A typical patient is a 62-year-old male with a history of coronary artery disease and prior percutaneous coronary intervention who presents for routine follow-up in primary care or cardiology clinic. The visit includes medication reconciliation, assessment of ischemic risk, and chronic secondary prevention counseling. The provider documents current use of antiplatelet therapy (aspirin or clopidogrel) and either prescribes, renews, or discontinues therapy based on clinical status, bleeding risk, and concurrent medications. The clinical workflow includes medication history verification, evaluation of indications (prior myocardial infarction, recent stent placement, ischemic stroke, or symptomatic coronary disease), review for contraindications (active bleeding, allergy), and documentation in the medical record that the patient is currently taking or has been prescribed aspirin or clopidogrel. Typical sites of service are outpatient primary care clinics, cardiology offices, and ambulatory surgical centers for pre-procedure medication management. The service is commonly coded when the provider explicitly documents antiplatelet therapy as part of chronic disease management or peri-procedural planning.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service on the same day

CPT 4014F: Performance Measure for Clinical Quality Reporting

CPT-4134F-CLINICAL-PERFORMANCE-ENTRY

CPT 4134F: Clinical Performance Entry

CPT-4172F-NO-ESA-PRESCRIPTION-CKD-ANEMIA

CPT 4172F: No ESA Prescribed for Anemia in Chronic Kidney Disease

CPT-4560F-UNKNOWN-SERVICE

CPT 4560F: Unspecified Service

CPT-4271F-UNSPECIFIED-CLINICAL-MEASURE

CPT 4271F: Unspecified Clinical Measure

CPT-4100F-PERFORMANCE-MEASURE

CPT 4100F: Clinical Performance Measure

CPT-4242F-NO-SUMMARY-AVAILABLE

CPT 4242F: No Summary Available

CPT-4540F-SPECIFIC-CLINICAL-MEASURE

CPT 4540F: Specific Clinical Measure

CPT-4064F-UNDEFINED-CLINICAL-MEASURE

CPT 4064F: Undefined Clinical or Administrative Measure

CPT-4185F-UNKNOWN-SERVICE

CPT 4185F: Undocumented CPT Code

Showing 1–10 of 175

Taxonomy Code	Specialty	Notes
`207RC0000X`	Cardiology	Cardiologists commonly manage antiplatelet therapy for coronary artery disease and post-stent care.
`207RG0300X`	Interventional Cardiology	Interventional cardiologists manage peri-procedural antiplatelet regimens for PCI and stent patients.
`207QG0300X`	General Cardiology	General cardiology practices provide ongoing secondary prevention and medication management.
`208D00000X`	Internal Medicine	Primary care physicians reconcile and prescribe antiplatelet therapy for chronic cardiovascular disease.
`208000000X`	Family Medicine	Family practitioners manage long-term antiplatelet therapy and routine preventive care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`I25.10`	Atherosclerotic heart disease of native coronary artery without angina pectoris	Indicates coronary artery disease for which `aspirin` or `clopidogrel` is commonly prescribed for secondary prevention.
`I21.9`	Acute myocardial infarction, unspecified	Acute MI is an indication for initiation of dual or single antiplatelet therapy during acute and post-acute management.
`I63.9`	Cerebral infarction, unspecified	Ischemic stroke patients may receive antiplatelet therapy for secondary prevention when appropriate.
`I20.9`	Angina pectoris, unspecified	Patients with symptomatic coronary ischemia may be maintained on antiplatelet agents.
`Z95.5`	Presence of coronary angioplasty implant and graft	Presence of coronary stent indicates need for ongoing antiplatelet therapy to prevent stent thrombosis.
`D68.9`	Coagulation defect, unspecified	Coagulopathy influences antiplatelet prescribing decisions; documentation is relevant when prescribing or withholding therapy.
`K92.2`	Gastrointestinal hemorrhage, unspecified	Active or recent GI bleeding is a contraindication or requires caution when prescribing antiplatelet agents.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for outpatient visits where antiplatelet therapy is prescribed, renewed, or reconciled as part of routine management.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used when a more complex visit is required to assess ischemic and bleeding risk and adjust antiplatelet therapy.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Often performed alongside medication management when assessing ischemic symptoms or evaluating cardiac status before adjusting antiplatelet therapy.
`92928`	Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	Interventional procedure after which long-term antiplatelet therapy is typically prescribed and managed.
`36415`	Collection of venous blood by venipuncture	Commonly performed when laboratory monitoring (e.g., hemoglobin, platelet count) is required before or during antiplatelet therapy.

OpenPayer